Amp up deprescribing? Sure, but docs and pharmacists need to learn to cooperateWhile deprescribing has had momentum over the last few years, its implementation faces some obstacles. Nasal spray for tachycardia: nothing to sniff atTrials show it’s safe, effective and easy to use for PSVT episodes. Apretude (cabotegravir) long-acting injection is now available for HIV PrEP The first antiretroviral injectable for HIV prevention in Canada is administered every two months and can be used with or without an oral antiretroviral lead-in period. Drug News—July 2024 A review of new launches, new indications, new dosage forms and Health Canada advisories. POP QUIZ: Velsipity for ulcerative colitis Can you tell which of these statements is false? High-dose NSAID + PPI + colchicine? It’s probably pericarditis Pericarditis can be self-limiting and occur in younger persons with no previous cardiac history—and is thus likely underreported. Breast cancer drugs could fight prostate cancer The effectiveness of androgen-targeted treatments for prostate cancer tends to fade over time, so new strategies are urgently needed. JULY UPDATE: New indications for six drugs prescribers and pharmacists should know about Check out these new indications for six drugs as part of our July drug news roundup. NEW DRUG: Tecentriq SC for multiple cancer types Get the info you need on this new product, part of our drug news roundup for July. NEW DRUG: Ondexxya for rapid reversal of anticoagulation Get the info you need on this new product, part of our drug news roundup for July. First Previous 3 4 5 6 7 Next Last
